Internal Medicine · New Brunswick, NJ
NPI
1174728679
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
125 Paterson St, Clinical Academic Building Room 5100
New Brunswick, NJ, 08901
Phone (732) 235-7784
Groups this clinician bills Medicare through
Medicare paid, 2024
$78K
1,363 services
Medicare patients, 2024
233
Average age 70
Drug cost, 2024
$2.5M
859 prescriptions
Company payments, 2025
$32.21
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Darren N Seril was code 99215 (office e&m - established), 130 times for 88 patients. In total Darren N Seril billed 1,363 services in 41 codes, and Medicare paid $78K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 130 | 88 | $144.41 | $19K |
| 99232 Hospital E&M - Subsequent | Facility | 63 | 45 | $63.73 | $4,015 |
| 45380 Lower GI Endoscopy - Other | Facility | 52 | 52 | $137.35 | $7,142 |
| 99223 Hospital E&M - Initial | Facility | 51 | 49 | $136.98 | $6,986 |
| 43239 Upper GI Endoscopy | Facility | 34 | 34 | $86.57 | $2,943 |
| 43235 Upper GI Endoscopy | Facility | 12 | 12 | $82.34 | $988 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $100.13 | $1,101 |
By year: 2022 $74K for 1,642 services; 2023 $103K for 2,224 services; 2024 $78K for 1,363 services.
Medicare prescription drug claims, 2024
In 2024, the drug Darren N Seril prescribed most often to Medicare patients was Mesalamine, with 125 prescriptions and refills. In total Darren N Seril wrote 859 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mesalamine Generic | 125 | 250 | 30 | $71K |
| Omeprazole Generic | 73 | 195 | 27 | $1,197 |
| Famotidine Generic | 70 | 163 | 23 | $1,181 |
| Dicyclomine Hcl Generic | 68 | 118 | 24 | $1,520 |
| Pantoprazole Sodium Generic | 65 | 175 | 25 | $1,208 |
| Stelara Ustekinumab | 51 | 65 | Under 11 | $1.3M |
| Rinvoq Upadacitinib | 38 | 38 | Under 11 | $271K |
| Sulfasalazine Generic | 29 | 85 | Under 11 | $1,374 |
| Mercaptopurine Generic | 28 | 64 | 11 | $2,740 |
| Prednisone Generic | 23 | 29 | Under 11 | $148 |
| Balsalazide Disodium Generic | 19 | 35 | Under 11 | $3,566 |
| Creon Lipase/Protease/Amylase | 14 | 14 | Under 11 | $41K |
| Humira(Cf) Pen Adalimumab | 13 | 13 | Under 11 | $351K |
| Metronidazole Generic | 13 | 23 | Under 11 | $286 |
| Apriso Mesalamine | 13 | 23 | Under 11 | $13K |
Brand drugs: 236 claims; generic drugs: 623 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Darren N Seril $32.21 ($32.21 in general payments such as food, travel and fees) from 1 company. The largest payer was Janssen Biotech, Inc. with $32.21.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 1 | $32.21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.